The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.


Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
OpenAI Agent Breaches Australia Medicare Data Portal
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
3 clinical-grade skincare creams you really shouldn’t buy online
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Neuralink Expands Brain Implant Trials with 12 Global Patients
OpenAI to Preview GPT-6 Cyber AI Model for Cybersecurity
U.S. Dollar Hits Two-Month High as Oil, Treasury Yields Surge
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Mexico-US Trade Talks Delayed to October as Tariff Negotiations Continue
Airbus Finds A321neo Fuselage Quality Issue
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline 



